Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.
about
Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigmsTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesCurrent concept of neuromyelitis optica (NMO) and NMO spectrum disorders.Optic neuritis in neuromyelitis optica.Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosisNeuromyelitis optica - an update: 2007-2009Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disordersThe treatment of neuromyelitis optica.Treatment of neuromyelitis optica: current debate.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).New insights into neuromyelitis opticaCurrent options for the treatment of optic neuritis.AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersTreatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.Neuromyelitis optica mimicking intramedullary tumor.Immunotherapy of neuromyelitis optica.Treatment of Neuromyelitis Optica: Review and Recommendations.EFNS guidelines on diagnosis and management of neuromyelitis optica.The differential diagnosis of longitudinally extensive transverse myelitis.Treatment of neuromyelitis optica: an evidence based review.Monoclonal antibodies in neuroinflammatory diseases.Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.Neuromyelitis optica spectrum disorders.Therapeutic options in neuromyelitis optica spectrum disorders.Effects of early using azathioprine in the acute phase in neuromyelitis optica spectrum disorder.[Therapeutic options for autoimmune encephalomyelitis].Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica.Persistent microscopic active inflammatory lesions in the central nervous system of a patient with neuromyelitis optica treated with oral prednisolone for more than 40 years.Role of interleukin-6 in the pathogenesis of neuromyelitis opticaDiagnostik und Therapie der Neuromyelitis opticaTreatment strategies for neuromyelitis opticaNeuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
P2860
Q27006941-25AF19D1-79C9-4FEC-BF1B-171862C82BC1Q28245749-FA2D562D-B1A1-48F4-9535-E8341D9F6541Q30577078-85CAF9F4-42E5-4976-A609-D5CF3F616A59Q30610471-7911C8A5-9893-4DF7-A8D4-0F88FD69681EQ30676331-06BFAA06-899E-4099-A667-3F0D46B505EDQ30785267-87EB0C31-B0B7-4E9C-BC44-2B8B9D7CEBD4Q30945169-D470D039-C721-4952-98EE-5D678CA1804EQ33611158-24E501C9-0060-4194-A924-4EC89AD70746Q33670918-10762226-59EC-465E-8B41-500EB8044FBFQ33876453-ED37118F-6A62-44BC-B5EC-9C46FCE4C4B8Q34399291-61D7A029-F71B-4CD3-88FF-D0544A784EFAQ34409070-002884FF-2D75-4DDB-8724-2BCF14A32D27Q35052199-64FEC3BB-C4FA-4E6A-94BB-B2F5AE8F7D1FQ35539641-985F85EA-808A-4261-9C93-52EA684F62F2Q36173222-30797F6B-CDA9-448A-BBA1-5AD052B4C7F2Q36293971-9D39EE26-20F5-40F8-BE06-BFE57446C606Q36484394-F13F4C9B-44FE-4D45-8922-E03673DADE07Q36727762-8A773CA5-A4FE-47EB-A486-A3BAF3CE032DQ37061002-3B27EC71-A060-4AD4-9642-7C61188829CDQ37456974-C31B7EE1-9389-4F6D-AE87-581500A1B6F0Q37588037-92567227-8392-4DB7-9CF7-9A2502D75105Q37763266-A9DA8685-CCD5-4166-A200-30385E7C69D7Q37888959-0084D822-9C31-4186-B74B-420E201E7AF2Q37973248-6F6A9D87-6DF3-4FE4-9137-D8DC6D1E91E3Q38092121-4FC5B2EB-D824-45FA-8A10-33F385159ECAQ38171871-84F7B282-48BF-4C5D-8A1A-0AFA0FF718B5Q38197504-FC1C2AFE-A6EE-496A-A94B-99A7A68EB74FQ38229823-5476D486-5F50-4F30-8416-C93861E5C0BCQ38721559-B8485BB0-97E0-468F-9EA2-BA07640C8157Q38870861-AFD370C4-4543-403C-8268-FEB7F4E2DB32Q43607388-34B18E66-85DD-4689-9A38-28AF7EDC3C7CQ45832517-7D233152-E0FA-4583-9331-42D61CD0AE7FQ48436141-C64ED32C-C254-4E75-8A62-7FD8F2A6653EQ48682528-720DCF9A-4ED0-429D-96D0-80C523837669Q50551126-45D19300-91BB-4D7F-AC55-056B238A4196Q55419049-3CAF9B8C-8558-4980-80AC-7C578127921EQ56771765-700D4409-28DF-4F8A-B571-3FE58F93DEBDQ56986486-0C0CE4DA-4A17-4174-A90A-619105824FA9Q57298520-2E4BECDA-3FBF-40BF-B1F3-8EABC6A56F55Q57725942-8FBE5778-2ECF-42F3-BFB6-ACD4952172FC
P2860
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@ast
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@en
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@nl
type
label
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@ast
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@en
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@nl
prefLabel
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@ast
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@en
Low-dose corticosteroids reduc ...... ica: a retrospective analysis.
@nl
P2093
P2860
P356
P1476
Low-dose corticosteroids reduc ...... tica: a retrospective analysis
@en
P2093
P2860
P304
P356
10.1177/1352458507077189
P577
2007-07-10T00:00:00Z